Back
INmune Bio 10K Form
Sell
43
INMB
INmune Bio
Last Price:
4.89
Seasonality Move:
46.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INMB News And Ratings
See the #1 stock for the next 7 days that we like better than INMB
INMB Financial Statistics
Sales & Book Value
| Annual Sales: | $155K |
|---|---|
| Cash Flow: | $-6.99M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.74 |
| Price / Book: | 2.75 |
Profitability
| EPS (TTM): | -2.18000 |
|---|---|
| Net Income (TTM): | $-41.27M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
INmune Bio Earnings Forecast
Key INmune Bio Financial Ratios
- The Research & Development expenses have been 13,079.35% of Revenue.
- The Net Earning history of INMB is -19,360.00% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 2 years.
INmune Bio Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INMB |
| CUSIP: | 45782T |
| Website: | inmunebio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
INMB Technical Analysis vs Fundamental Analysis
Sell
43
INmune Bio (INMB)
is a Sell
Is INmune Bio a Buy or a Sell?
-
INmune Bio stock is rated a Sell
The current INmune Bio [INMB] share price is $4.80. The Score for INMB is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.